image of Bo Qiu
  • Telehealth Visits
bch logo

Bo Qiu, MD, PhD

He | Him | HisPediatrics
Pediatric Neuro-Oncology Oakland
877-822-4453
image of Bo Qiu
image of Bo Qiu
bch logo

Bo Qiu, MD, PhD

He | Him | HisPediatrics
Pediatric Neuro-Oncology Oakland
877-822-4453
  • Telehealth Visits

On this page

About me

Dr. Bo Qiu is a pediatric oncologist who cares for children with cancer. He has a particular focus on patients with high-risk tumors of the nervous system, including brain and spinal cord tumors and neuroblastoma.

In his research, Qiu investigates how cancer-causing genetic mutations rewire cells in the developing nervous system, with the goal of developing new therapies that specifically target these cancers.

Qiu earned his medical degree from the Perelman School of Medicine at the University of Pennsylvania, where he also earned a doctorate in cancer biology. At UCSF, he completed a residency in pediatrics and a fellowship in pediatric hematology-oncology.

Education

Board Certification

  • General Pediatrics, American Board of Pediatrics
  • Pediatric Hematology-Oncology, American Board of Pediatrics

Fellowship

  • Ped. Hema/Oncology, UCSF School of Medicine -GME

Residency

  • Pediatric Hematology-Oncology, UCSF School of Medicine -GME

School

  • MD, Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania

Academic Title

  • Adjunct Professor

Care Keywords

  • Services
    • Pediatrics

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.